World Health Summit 2021

FIND and the Max Planck Society hosted workshop 07 – Novel vaccine platforms for emerging pandemics and existing pandemics – on 25 October 2021.

Novel vaccine platforms for emerging pandemics and existing pandemics
COVID-19 has highlighted the value of vaccines for effective intervention. It took less than 12 months to develop vaccines for COVID-19 from drawing board to deployment. This speed was possible because of unlimited funding both from private and public resources, and availability of platforms for rapid design of novel vaccine types, notably RNA vaccines and viral-vectored vaccines. In the future, novel vaccine platforms will play an increasing role in rapid defeat of newly emerging pandemics and provide the basis for renewed attempts to combat existing epidemics such as HIV/AIDS, tuberculosis, malaria and hepatitis C for which effective vaccines are still not available. This workshop will discuss novel vaccine platforms (RNA vaccines, viral-vectored vaccines) and adjuvants for improved subunit vaccines and their value for better interventions of communicable diseases, as well as ways to accelerate development and deployment of novel vaccines.
Hosts:	FIND & Max Planck Society
Chair:	Prof. Dr Stefan Kaufmann, Max Planck Institute for Infection Biology, Director Emeritus
Speakers:	Nathalie Garçon, BioAster, CEO/CSO Dr Ann Ginsberg, BMGF, TB Vaccines, Global Health, Deputy Director Dr Wayne Koff, Human Vaccines Project, President Dr Bill Rodriguez, FIND, CEO Prof. Dr Leif Erik Sander, Charité-Universitätsmedizin, Group Leader Infection Immunology & Vaccinology Dr Melanie Saville, CEPI, Vaccine Research & Development, Director
View workshop